Renbo Zhao
Research Subjects
Research Interests
Renbo Zhao has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Hongliang Gao
Department of Orthopaedics, Huzhou Central Hospital, Huzhou
1 shared publication- Shengjun Qian
Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou China
1 shared publication Yuanxi Zhou
Department of Orthopaedics, Health Community Group of Yuhuan Second People's Hospital, Taizhou
1 shared publicationZhan Wang
Department of Orthopaedics, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
1 shared publication
Latest Publications
- Open Access
- 1 September 2019
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (36) , e17025
Clinical features and prognostic analysis of patients with chest wall chondrosarcoma
Chest wall chondrosarcoma is a rare malignant tumor of the bone. This study is aimed to identify the prognostic determinants of chest wall chondrosarcoma. We used the Surveillance, Epidemiology, and End Results (SEER) database to identify patients with chest wall chondrosarcoma from 1973 to 2015. Statistical analyses were performed using Kaplan–Meier method and Cox regression proportional hazards. A total of 779 patients were identified from the SEER database. The overall survival (OS) and cancer-specific survival (CSS) rates of the entire group at 10 years were 66.2% and 77.2%, respectively. On multivariate Cox regression, age ≤40 years, localized tumor stage, low tumor grade, surgery, and no radiotherapy were significantly associated with improved both OS and CSS. This study may help clinicians to predict survival of patients with chest wall chondrosarcoma and to provide appropriate treatment recommendations.
- 1 September 2019
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (36) , e17025
Open AccessClinical features and prognostic analysis of patients with chest wall chondrosarcoma
Chest wall chondrosarcoma is a rare malignant tumor of the bone. This study is aimed to identify the prognostic determinants of chest wall chondrosarcoma. We used the Surveillance, Epidemiology, and End Results (SEER) database to identify patients with chest wall chondrosarcoma from 1973 to 2015. Statistical analyses were performed using Kaplan–Meier method and Cox regression proportional hazards. A total of 779 patients were identified from the SEER database. The overall survival (OS) and cancer-specific survival (CSS) rates of the entire group at 10 years were 66.2% and 77.2%, respectively. On multivariate Cox regression, age ≤40 years, localized tumor stage, low tumor grade, surgery, and no radiotherapy were significantly associated with improved both OS and CSS. This study may help clinicians to predict survival of patients with chest wall chondrosarcoma and to provide appropriate treatment recommendations.